We are getting closer to the possibility of people with type 1 diabetes (T1D) needing to administer basal insulin only once a week instead of every single day, with Novo […]
New results from a clinical trial of once-weekly insulin
JDRF is deeply saddened by the loss of one of its founding family members, Susan Gold-Reich, a remarkable individual whose dedication and passion changed the landscape of Type 1 Diabetes (T1D) in Canada
Susan’s journey began when her daughter, Amy, was diagnosed with T1D at a young age. Determined to make a difference, Susan, alongside four other families, embarked on a remarkable journey. […]
Ross Chocolates is a proud supporter of diabetes research
Ross Chocolates, a longtime corporate partner of JDRF Canada is generously providing a matching gift in honour of National Diabetes Awareness Month. All donations made throughout November will be matched […]
JDRF’s Legal Sector Challenge: Taking Bold Steps to Accelerate Type 1 Diabetes Research
When we come together as a collective, we can accomplish great things. A dedicated group of lawyers and law firms from across Canada rallied together this year to support JDRF’s […]
The Sun Life Ride to Defeat Diabetes was a great success!
One of Canada’s longest running and top fundraising events held Rides in Montréal, Toronto and Calgary, on October 5, 12 and 19, 2023 respectively, along with community ‘Ride Your Way’ […]
Halloween Guide
For many families newly diagnosed with type 1 diabetes (T1D), Halloween can feel overwhelming – a holiday centered on candy when you’re just figuring out carb counting and nutrition. However, […]
JDRF Golf Challenge a great success
Once again in 2023, David Garfinkle and Steven Mitchell – along with a team of supporters rallied Canadians to come together to support type 1 diabetes (T1D) research by committing […]
New JDRF Canada and Stem Cell Network recipient of the J. Andrew McKee Fellowship in Type 1 Diabetes
Dr. Sing-Young Chen is a postdoctoral researcher at the JDRF Centre of Excellence at the University of British Columbia, and the second annual recipient of a J. Andrew McKee Fellowship […]
Results are out: TZIELD (teplizumab) benefits individuals newly diagnosed with type 1 diabetes
In a coordinated release of information today, Dr. Kevan Herold (Yale University) presented the PROTECT clinical trial results at the International Society for Paediatric and Adolescent Diabetes (ISPAD) conference simultaneous […]
Building capacity for the future of type 1 diabetes research
Training the next generation of researchers and clinicians in type 1 diabetes (T1D) is a central goal of JDRF’s global research strategy. Support of these emerging leaders is essential to […]
Ontario life sciences startup, Allarta, receives award from JDRF International to advance its work in creating a functional cure for type 1 diabetes
Hamilton, ON, Canada and New York, NY – On October 3, 2023, Allarta Life Science, a Hamilton, Ontario-based regenerative medicine company announced it has received an award from JDRF International […]
Study Suggests Semaglutide Increases Insulin Production in Newly Diagnosed People with Type 1 Diabetes
Semaglutide, brand names Ozempic®, Rybelsus®, and Wegovy®, is all over the news. It is Health Canada-approved to help people with type 2 diabetes (T2D) manage their blood glucose levels. It […]
